These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4360189)

  • 1. Influence of immune suppression on the induction of neoplasms by MLV and MSV.
    Law LW
    Bibl Haematol; 1973; 39():662-70. PubMed ID: 4360189
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostasis of lymphoma cells in suspension: probable non-thymic origin of the cytostatic lymphoid cells in mice bearing mys -induced tumors.
    Senik A; de Giorgi L; Gomard E; Levy JP
    Int J Cancer; 1974 Sep; 14(3):396-400. PubMed ID: 4376521
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune response to viral infection: in vitro studies of lymphocytes from mice infected with Sindbis virus.
    Griffin DE; Johnson RT
    Cell Immunol; 1973 Dec; 9(3):426-34. PubMed ID: 4543313
    [No Abstract]   [Full Text] [Related]  

  • 9. Ribonucleic acid components of murine sarcoma and leukemia viruses.
    Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes.
    Shirai T; Yoshiki T; Mellors RC
    J Immunol; 1973 Feb; 110(2):517-23. PubMed ID: 4539675
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of different lymphoid target cells in determining the correlation of in vitro and in vivo activities of antilymphocyte sera.
    Végh P; Balough E; Jánossy T; Erdös E
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):162-74. PubMed ID: 4283007
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in lymphocyte populations in tumorigenesis. I. Lymphocyte trapping.
    Zatz MM; White A; Goldstein AL
    J Immunol; 1973 Sep; 111(3):706-11. PubMed ID: 4741294
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia induction in C3H mice following their inoculation with normal AKR lymphoid cells.
    Nemirovsky T; Trainin N
    Int J Cancer; 1973 Jan; 11(1):172-7. PubMed ID: 4151449
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.
    Gorczynski RM
    J Immunol; 1974 Feb; 112(2):533-9. PubMed ID: 4360545
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immunity to moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice.
    Knight RA; Gorczynski RM
    Int J Cancer; 1975 Jan; 15(1):48-58. PubMed ID: 47841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific "arming" of normal lymph-node cells by sera from tumor-bearing mice.
    Pollack S
    Int J Cancer; 1973 Jan; 11(1):138-42. PubMed ID: 4790833
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of the immunological capacity of germ-free mouse radiation chimeras. II. Thymus cell function in a humoral immune response to sheep erythrocytes.
    Loughman BE; Nordin AA
    Cell Immunol; 1973 Oct; 9(1):118-26. PubMed ID: 4582619
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB; Aoki T; Silverman TN
    Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.